Testing effectiveness (Phase 2)Ended earlyNCT03381833
What this trial is testing
A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia
Who this might be right for
Beta-Thalassemia
La Jolla Pharmaceutical Company 84